New article in Medtech Strategist !
October 14th 2025
🚀 Focused ultrasound is transforming therapy — and Cardiawave is proud to be part of the movement.
We are honored to be featured by @MedTech Strategist alongside other pioneering start-ups like SonoMotion and Openwater. Our noninvasive solution for treating aortic stenosis is helping redefine cardiovascular care — safely, precisely, and without surgery: https://www.linkedin.com/feed/update/urn:li:activity:7379198421892595713/?actorCompanyId=26415925
🔬 This article highlights how focused ultrasound is attracting major investment and reshaping treatment pathways across medtech.
[Valvosoft® is a medical device exclusively intended for clinical investigations (not CE marked or approved for marketing).]
#medicaldevices #medtech #startups #cardiovascular #focusedultrasound #Cardiawave #Valvosoft #NIUT
#HEGP, @AP-HP, Assistance Publique – Hôpitaux de Paris @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub
